FDAnews Device Daily Bulletin

FDA Clears Xavant Tech’s Pain Relief Neuromod

Aug. 7, 2017

Xavant Technology announced FDA clearance for its Stimpod non-invasive pain relief neuromodulation device.

The device treats chronic, post-surgical and post-traumatic acute pain through a hybrid pulsed radio frequency waveform. The system uses nerve-locating technology and nerve mapping to track and assess treatment progress.

The South African company said it will use Bell Medical as its distributor for the device in the United States and Canada.

View today's stories